• 한국컴퓨터정보학회논문지
• /
• 제17권11호
• /
• pp.141-148
• /
• 2012

인간 유전체 정보와 관련된 기술이 발전함으로 인하여 이를 이용한 질환 또는 질병에 대한 연관성을 분석하여 그 위험도나 치료 예후 등에 대한 예측하기 위한 연구가 활발히 진행되고 있다. 이러한 연구의 대부분은 대표적인 질적 표현형을 대상으로 하는 환자-대조군 연구(case-control study) 방법을 이용하고 있으며 양적 표현형에 대해서는 개별 단일 염기 변이의 연관성을 회기 분석 방법을 이용하여 규명하는 연구가 주로 수행되고 있다. 특히 복합 질병(complex disease)에 대한 위험도를 예측하기 위한 연구의 경우 흔한 변이 흔한 질환(common variants common disease)의 가정아래 주로 각각의 단일 염기 변이가 보이는 연관성 정보를 기반으로 진행되고 있으며 여러 변이의 상호 작용에 의한 영향을 분석한 결과는 상대적으로 미비하다. 이 논문에서는 양적 표현형에 대한 SNP의 연관성을 분석하고 그 결과로 발견된 SNP을 이용하여 대상 표현형의 값을 예측하기 위한 분류기를 구성하고 그 성능을 평가하였으며 분류기의 단일 염기 변이의 선택에 있어서 각각의 단일 염기 변이의 연관성을 고려할 때와 단일 염기 변이의 쌍이 보이는 연관성을 고려할 때의 분류 성능을 비교하였다.

• Genomics & Informatics
• /
• 제12권4호
• /
• pp.181-186
• /
• 2014

Genome-wide association studies have proven the highly polygenic architecture of complex diseases or traits; therefore, single-locus-based methods are usually unable to detect all involved loci, especially when individual loci exert small effects. Moreover, the majority of associated single-nucleotide polymorphisms resides in non-coding regions, making it difficult to understand their phenotypic contribution. In this work, we studied epistatic interactions associated with three common diseases using Korea Association Resource (KARE) data: type 2 diabetes mellitus (DM), hypertension (HT), and coronary artery disease (CAD). We showed that epistatic single-nucleotide polymorphisms (SNPs) were enriched in enhancers, as well as in DNase I footprints (the Encyclopedia of DNA Elements [ENCODE] Project Consortium 2012), which suggested that the disruption of the regulatory regions where transcription factors bind may be involved in the disease mechanism. Accordingly, to identify the genes affected by the SNPs, we employed whole-genome multiple-cell-type enhancer data which discovered using DNase I profiles and Cap Analysis Gene Expression (CAGE). Assigned genes were significantly enriched in known disease associated gene sets, which were explored based on the literature, suggesting that this approach is useful for detecting relevant affected genes. In our knowledge-based epistatic network, the three diseases share many associated genes and are also closely related with each other through many epistatic interactions. These findings elucidate the genetic basis of the close relationship between DM, HT, and CAD.

• Clinical and Experimental Reproductive Medicine
• /
• 제38권3호
• /
• pp.126-134
• /
• 2011

Preimplantation genetic diagnosis (PGD) is gradually widely used in prevention of gene diseases and chromosomal abnormalities. Much improvement has been achieved in biopsy technique and molecular diagnosis. Blastocyst biopsy can increase diagnostic accuracy and reduce allele dropout. It is cost-effective and currently plays an important role. Whole genome amplification permits subsequent individual detection of multiple gene loci and screening all 23 pairs of chromosomes. For PGD of chromosomal translocation, fluorescence $in-situ$ hybridization (FISH) is traditionally used, but with technical difficulty. Array comparative genomic hybridization (CGH) can detect translocation and 23 pairs of chromosomes that may replace FISH. Single nucleotide polymorphisms array with haplotyping can further distinguish between normal chromosomes and balanced translocation. PGD may shorten time to conceive and reduce miscarriage for patients with chromosomal translocation. PGD has a potential value for mitochondrial diseases. Preimplantation genetic haplotyping has been applied for unknown mutation sites of single gene disease. Preimplantation genetic screening (PGS) using limited FISH probes in the cleavage-stage embryo did not increase live birth rates for patients with advanced maternal age, unexplained recurrent abortions, and repeated implantation failure. Polar body and blastocyst biopsy may circumvent the problem of mosaicism. PGS using blastocyst biopsy and array CGH is encouraging and merit further studies. Cryopreservation of biopsied blastocysts instead of fresh transfer permits sufficient time for transportation and genetic analysis. Cryopreservation of embryos may avoid ovarian hyperstimulation syndrome and possible suboptimal endometrium.

• 한국생물정보학회:학술대회논문집
• /
• 한국생물정보시스템생물학회 2005년도 BIOINFO 2005
• /
• pp.395-398
• /
• 2005

Genetic association case-control studies using DNA pools are efficient ways of detecting association between a marker allele and disease status. DNA pooling is an efficient screening method for locating susceptibility genes associated with the disease. However, DNA pooling is efficient only when allele frequency estimation is done precisely and accurately. Through the evaluation of empirical type I errors and empirical powers by simulation, we will evaluate the methods that correct for preferential amplification of nucleotides when estimating the allele frequency of single-nucleotide polymorphisms.

• 한국작물학회:학술대회논문집
• /
• 한국작물학회 2000년도 추계 학술대회지
• /
• pp.184-185
• /
• 2000

• Biotechnology and Bioprocess Engineering:BBE
• /
• 제5권5호
• /
• pp.307-312
• /
• 2000

As the first assembly of the human genome was announced on June 26, 2000, we have entered post genome era. The genome sequence represents a new starting point for science and medicine with possible impact on research across the life sciences. In this review I tried to offer brief summaries of history and progress of the Human Genome Project and two major challenges ahead, functional genomics and DNA sequence variation research.

• 대한생식의학회:학술대회논문집
• /
• 대한불임학회 2006년도 제51차 추계학술대회
• /
• pp.136-137
• /
• 2006

• 대한생식의학회:학술대회논문집
• /
• 대한불임학회 2006년도 제51차 추계학술대회
• /
• pp.119-119
• /
• 2006

• 대한약학회:학술대회논문집
• /
• 대한약학회 2001년도 Proceedings of International Convention of the Pharmaceutical Society of Korea
• /
• pp.98-98
• /
• 2001

• Genomics & Informatics
• /
• 제5권4호
• /
• pp.161-167
• /
• 2007

Glucuronidation by the uridine diphosphateglucuronosy-ltransferase 1A enzymes (UGT1As) is a major pathway for elimination of particular drugs and endogenous substances, such as bilirubin. We examined the relation of eight single nucleotide polymorphisms (SNPs) and haplotypes of the UGT1A gene with their clinical factors. For association analysis, we genotyped the variants by direct sequencing analysis and polymerase chain reaction (PCR) in 218 healthy Koreans. The frequency of UGT1A1 polymorphisms, -3279T>G, -3156G>A, -53 $(TA)_{6>7}$, 211G>A, and 686C>A, was 0.26, 0.12, 0.08, 0.15, and 0.01, respectively. The frequency of -118 $(T)_{9>10}$ of UGT1A9 was 0.62, which was significantly higher than that in Caucasians (0.39). Neither the -2152C>T nor the -275T>A polymorphism was observed in Koreans or other Asians in comparison with Caucasians. The -3156G>A and -53 $(TA)_{6>7}$ polymorphisms of UGT1A were significantly associated with platelet count and total bilirubin level (p=0.01, p=0.01, respectively). Additionally, total bilirubin level was positively correlated with occurrence of the UGT1A9-118 $(T)_{9>10}$ rare variant. Common haplotypes encompassing six UGT1A polymorphisms were significantly associated with total bilirubin level (p=0.01). Taken together, we suggest that determination of the UGT1A1 and UGT1A9 genotypes is clinically useful for predicting the efficacy and serious toxicities of particular drugs requiring glucuronidation.